Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-06-14
1991-02-19
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514903, A61K 3144
Patent
active
049944665
ABSTRACT:
A method of treating a patient suffering from multiple sclerosis comprising daily administration to such patient of from about 1 to about 100 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided doses from one to four times daily, preferably by the oral route. Parenteral, transmucosal and transdermal administration may be utilized where suitable.
REFERENCES:
patent: 4877791 (1989-10-01), Sherman
patent: 4923875 (1990-05-01), Frost
Y. Olsson et al., Acta Neurol. Scandinav., 50:611-618, (1974).
D. Johnson et al., Ann. New York Acad. Sci., 1989, 727-728.
C. M. S. Fewtrell et al., J. Physiol., 330:393-411, (1982).
S. K. Kostyk et al., Brain Res., 504:284-288, (1989).
W. I. Rosenblum, Brain Res., 49:75-82, (1973).
K. Sugiyama, Nature, 370:614-615, (1977).
G. N. Dietsch et al., J. Immun., 142:1476-1481, (1989).
E. Orr, Ann. New York Acad. Sci., 1989, 723-726.
Casale et al., J. Aller. Clin. Immunol., 73:775-781, (1984).
Hahn Elliot
Sherman Fred P.
Baker Cummins Pharmaceuticals, Inc.
Friedman Stanley J.
Henley III Raymond J.
LandOfFree
Method of treatment for multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment for multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143879